Floatz logo

6-(3-(4-(O-METHOXYPHENYL)-1-PIPERAZINYL)PROPYLAMINO)-1,3-DIMETHYLURACIL

Cerebral Hemorrhage

The George InstituteSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

40 Active assets in the Cerebral Hemorrhage cohort.

Asset / SponsorPhaseRating
Edoxaban
Population Health Research Institute
Phase 4BBB
Tranexamic Acid
Christian Medical College and Hospital, Ludhiana, India
Phase 4BB
Acetylsalicylic Acid
University Hospital, Lille
Phase 4BB
Rivaroxaban
Imperial College London
Phase 3BB
Valproic Acid
University of North Carolina, Chapel Hill
Phase 4BB

View all 50 →

Same molecule, other indications

6-(3-(4-(O-METHOXYPHENYL)-1-PIPERAZINYL)PROPYLAMINO)-1,3-DIMETHYLURACIL is also rated in:

stroke disorderDormant
BB
Indicative ·
64 / 100
View asset →
cerebrovascular disorderDormant
B
Indicative ·
62 / 100
View asset →
ischemic strokeDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →